Financhill
Sell
15

SOLTF Quote, Financials, Valuation and Earnings

Last price:
$5.15
Seasonality move :
2.46%
Day range:
$5.15 - $5.15
52-week range:
$4.90 - $7.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.41x
P/B ratio:
1.05x
Volume:
--
Avg. volume:
223
1-year change:
-21.01%
Market cap:
$466M
Revenue:
$190.3M
EPS (TTM):
-$0.46

Earnings Data

Next earnings date for SOLTF
Feb 13
2026
Most recent earnings per share
-$0.13
Missed by $0.13
(Oct 31/2025)
Consensus Estimate
--
(Oct 31/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SOLTF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
10/31/2025 Q3 -- $45.8M -$0.13 -- --
08/08/2025 Q2 -- $58.5M -$0.18 -- --
05/09/2025 Q1 -- $43.6M -$0.06 -- --
12/31/2024 Q4 -- $45M -$0.10 -- --
09/30/2024 Q3 -- $62.1M $0.09 -- --
06/30/2024 Q2 -- $52M -$0.10 -- --
03/31/2024 Q1 -- $31.1M -$0.25 -- --
12/31/2023 Q4 -- $49.3M -$0.02 -- --
09/30/2023 Q3 -- $23M -$0.41 -- --
06/30/2023 Q2 -- $8.7M -$0.06 -- --
03/31/2023 Q1 -- $7.1M -$0.13 -- --
12/31/2022 Q4 -- $49M $0.31 -- --
09/30/2022 Q3 -- $44.7M $0.03 -- --
06/30/2022 Q2 -- $10.3M -$0.14 -- --
03/31/2022 Q1 -- $9.6M -$0.22 -- --
12/31/2021 Q4 -- $124.2M $0.31 -- --
09/30/2021 Q3 -- $4.2M $0.05 -- --
06/30/2021 Q2 -- $17.5M -$0.13 -- --
03/31/2021 Q1 -- $11.4M -$0.13 -- --
12/31/2020 Q4 -- $42.1M $0.37 -- --
09/30/2020 Q3 -- $18.2M $0.06 -- --
06/30/2020 Q2 -- $12.6M -$0.17 -- --
03/31/2020 Q1 -- $10.7M -$0.09 -- --
12/31/2019 Q4 -- $18M -$0.00 -- --
09/30/2019 Q3 -- $25.3M $0.13 -- --
06/30/2019 Q2 -- $17.5M -$0.07 -- --
03/31/2019 Q1 -- $28.5M $0.12 -- --
12/31/2018 Q4 -- $9.5M -$0.31 -- --
09/30/2018 Q3 -- $8.7M -$0.24 -- --
06/30/2018 Q2 -- $7.6M -$0.19 -- --
03/31/2018 Q1 -- $8.8M -$0.06 -- --
12/31/2017 Q4 -- $8.5M -$0.15 -- --
09/30/2017 Q3 -- $22.8M -$0.13 -- --
06/30/2017 Q2 -- $25.1M $0.04 -- --
03/31/2017 Q1 -- $15.7M -$0.12 -- --
12/31/2016 Q4 -- $11.7M $0.01 -- --
09/30/2016 Q3 -- $7.4M -$0.14 -- --
06/30/2016 Q2 -- $139.8M $1.52 -- --
03/31/2016 Q1 -- $3.6M -$0.48 -- --

Nxera Pharma Co., Ltd. Earnings Questions

  • How Much did Nxera Pharma Co., Ltd. Generate in Revenue Last Quarter?

    Nxera Pharma Co., Ltd. reported $45.8M worth of top line sales in its most recent quarter.

  • Did Nxera Pharma Co., Ltd. Beat Earnings Last Quarter?

    Nxera Pharma Co., Ltd. announced earnings per share of -$0.13 which represents a miss of analyst forecast a -- per share.

  • Is Nxera Pharma Co., Ltd. Profitable?

    Nxera Pharma Co., Ltd. reported $27.7M that represents $0.31 per share over the last quarter.

  • What is the Analyst Consensus for Nxera Pharma Co., Ltd. EPS Next Year?

    Nxera Pharma Co., Ltd.'s earnings are forecast to grow from -$0.36 per share to -- per share next year representing an increase of --.

  • When is Nxera Pharma Co., Ltd.'s Earnings Date?

    Nxera Pharma Co., Ltd.'s next earnings date is February 13, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoundHound AI Stock Go Up?
Why Did SoundHound AI Stock Go Up?

SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…

Is Goldman Sachs Going to Go Up?
Is Goldman Sachs Going to Go Up?

Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…

How High Will MSTR Stock Go?
How High Will MSTR Stock Go?

After several months of pressure, shares of Bitcoin treasury Strategy…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
48
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
69
INTC alert for Jan 23

Intel Corp. [INTC] is down 17.43% over the past day.

Buy
51
APGE alert for Jan 23

Apogee Therapeutics, Inc. [APGE] is down 12.91% over the past day.

Buy
70
BNR alert for Jan 23

Burning Rock Biotech Ltd. [BNR] is down 13.61% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock